RIZZUTO, MARIA ANTONIETTA

RIZZUTO, MARIA ANTONIETTA  

DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.018 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Conjugation of gold nanoparticles with multidentate surfactants for enhanced stability and biological properties 01 - Articolo su rivista 2023 Rotem, RGiustra, MArrigoni, FBertolini, JAGarbujo, SRizzuto, MASalvioni, LBarbieri, LBertini, LDe Gioia, LColombo, MProsperi, D
Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2 01 - Articolo su rivista 2023 Rotem, RBertolini, JASalvioni, LBarbieri, LRizzuto, MATinelli, VGori, AColombo, MProsperi, D +
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 01 - Articolo su rivista 2022 Marongiu L.Mingozzi F.Marzi R.Cigni C.Facchini F. A.Rotem R.Valache M.Gornati L.Rizzuto M. A.Salvioni L.Zanoni I.Gori A.Prosperi D.Granucci F. +
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages 01 - Articolo su rivista 2021 Prosperi D.Rizzuto M. A.Bellini M. +
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax 01 - Articolo su rivista 2021 Rizzuto, Maria AntoniettaProsperi, Davide +
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 01 - Articolo su rivista 2021 Rizzuto, Maria AntoniettaDal Magro, RobertaBarbieri, LindaPandolfi, LauraSalvioni, LuciaColombo, MiriamRe, FrancescaProsperi, Davide +
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 01 - Articolo su rivista 2020 Bellini M.Riva B.Rizzuto M. A.Salvioni L.Colombo M.Mingozzi F.Marongiu L.Frascotti G.Prosperi D.Fiandra L. +
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems 01 - Articolo su rivista 2020 Rotem R.Rizzuto M. A.Giustra M.Salvioni L.Prosperi D.Colombo M. +
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 01 - Articolo su rivista 2019 Avvakumova S.Pandolfi L.Bellini M.Galbiati E.Rizzuto M. A.Colombo M.Prosperi D. +
Thirty years of cancer nanomedicine: Success, frustration, and hope 01 - Articolo su rivista 2019 Salvioni L.Rizzuto M. A.Bertolini J. A.Colombo M.Prosperi D. +
Exploiting Nanotechnology to Improve Cancer Immunotherapy and Overcome Biological Barriers 07 - Tesi di dottorato Bicocca post 2009 2019 RIZZUTO, MARIA ANTONIETTA
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer 02 - Intervento a convegno 2019 Colombo M.Rizzuto M. A.Pandolfi L.Fiandra L.Prosperi D. +
Are nanotechnological approaches the future of treating inflammatory diseases? 01 - Articolo su rivista 2019 Rizzuto M. A.Salvioni L.Rotem R.Colombo M.Zanoni I.Granucci F.Prosperi D.
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 01 - Articolo su rivista 2018 Riva, BenedettaBellini, MichelaVerderio, PaoloColzani, BarbaraAvvakumova, SvetlanaRizzuto, Maria AntoniettaColombo, MiriamProsperi, Davide +
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer 01 - Articolo su rivista 2018 Colombo, MiriamRIZZUTO, MARIA ANTONIETTAPandolfi, LauraGiustra, MarcoGarbujo, StefaniaFiandra, LuisaProsperi, Davide +
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer 02 - Intervento a convegno 2017 Bellini M.Rizzuto M. A.Prosperi D. +
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 01 - Articolo su rivista 2017 BELLINI, MICHELAFIANDRA, LUISARIZZUTO, MARIA ANTONIETTAPROSPERI, DAVIDE +
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer 01 - Articolo su rivista 2017 Bellini, M.Rizzuto, M. A.Prosperi, D. +
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 01 - Articolo su rivista 2017 Pandolfi, LauraBellini, MichelaAvvakumova, SvetlanaBertolini, Jessica ArmidaRizzuto, Maria AntoniettaColombo, MiriamProsperi, Davide +
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 01 - Articolo su rivista 2014 BELLINI, MICHELAMAZZUCCHELLI, SERENAGALBIATI, ELISABETTAFiandra, LRIZZUTO, MARIA ANTONIETTACOLOMBO, MIRIAMTORTORA, PAOLOPROSPERI, DAVIDE +